This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Pancreatin

Authoring team

  • pancreatin is used for pancreatic enzyme replacement therapy - it contains varying amounts of protease (trypsin, chymotrypsin, elasase), lipase and amylase, which help with the digestion of protein, fat and starch respectively

  • pancreatin is used in conditions such as cystic fibrosis, and following pancreatectomy, total gastrectomy and chronic pancreatitis

  • compared to trypsin and amylase, pancreatic lipase is more susceptible to acid denaturation - therefore it is easier to treat protein malabsorption with standard pancreatin supplements than fat malabsorption (steatorrhoea); gastric acid secretion may be reduced via adjuvant therapy with H2-antagonists or proton pump inhibitors

  • there is evidence that pancreatin relieves pain in chronic pancreatitis

  • side effects of pancreatin include:
    • abdominal discomfort
    • nausea and vomiting
    • diarrhoea or constipation
    • hypersensitivity to pancreatin supplement
    • buccal and perioral irritation if pancreatin retained in the mouth
    • excessive doses can cause perianal irritation
    • hyperuricosuria and hyperuricaemia have been associated with the use of very high doses of pancreatin
    • fibrosing colonopathy

Check SPC before prescribing pancreatin.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.